Combining pregnancy carrier and cancer risk screening
Part of Cancer, Genetic & congenital clinical trials.
This study combines routine obstetrical carrier screening with hereditary cancer risk screening in one blood draw. It aims to see if offering both tests together is feasible and helpful for patients receiving OB care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 55 years old.
- You are receiving obstetrical care at a Columbia University Medical Center-affiliated site.
- You have chosen to have obstetrical carrier screening (OCS) through your OB provider.
- If you had OCS before, you are willing to repeat it now.
- You can read and speak English or Spanish.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study helps clinics roll out cancer genetic counseling services for people who may have inherited cancer risk. If you may need genetic testing for hereditary breast or colon cancer, you can be interviewed about your experience with these services.
This study looks for DNA fragments in blood of people with certain inherited cancer syndromes. It may help find cancer earlier or guide better monitoring. You would give blood samples every 4 months (if in the experimental group).
This trial offers a combined genetic test for both common inherited conditions and hereditary cancer risks to pregnant women or those planning pregnancy. It aims to see if adding cancer screening to routine pregnancy testing is helpful.
This study tests a new online way to offer genetic testing and counseling for people concerned about hereditary cancer. It aims to make it easier and faster to access these services from home.
This study offers free genetic testing to women ages 25-39 who receive gynecologic care at certain NYU Langone Health clinics. The goal is to find inherited gene changes that may increase risk for ovarian and related cancers, so you can take steps to reduce your risk.
This study helps Black and Hispanic women ages 45-74 get both breast and colorectal cancer screenings and genetic services. It provides a navigator to guide you through the process.
Hear when a new Hereditary Cancer Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.